- 2019 (1)
- 2018 (10)
- 2017 (1)
- 2016 (3)
MIMS Announces Growth, Expansion to New Office in Taiwan
Singapore, February 1, 2018 – MIMS, a leading multichannel provider of drug information, medical communications and technology solutions in Asia Pacific, is pleased to announce the opening of a new branch office in Taiwan located at 20th floor, No.97, SEC.2, Dun Hua S. Rd., Taipei, Taiwan.
The latest expansion meets growing demand in Taiwan for medical communications services in the healthcare industry. The new Taiwan branch has a professional team of members from both Taiwan and Hong Kong delivering medical communications solutions catering to the Taiwan market, with a regional perspective and through a multidisciplinary and integrated approach.
“MIMS brings to Taiwan deep expertise in medical communications and strategy,” stated Victor Wright, Regional VP of Medical Communications APAC. “MIMS takes pride in bringing exceptional scientific content and events management along with rigorous editorial standards and strict regulatory compliance. It’s an exciting opportunity for MIMS to provide best-in-class solutions to the Taiwan pharmaceutical industry.”
Prior to the official opening in Taipei, MIMS has offered these services to several multinational pharmaceutical companies in Taiwan.
MIMS has a leading position in the Asia-Pacific healthcare landscape, anchored in its drug reference publications historically. In the past decade, it has evolved to develop progressive digital solutions to empower doctors and healthcare communities to improve patient outcomes.